Acute versus chronic exposure to androgen suppression for prostate cancer: Impact on the exercise response

Authors

Daniel A. Galvao, Edith Cowan UniversityFollow
Dennis R. Taaffe, University of NewcastleFollow
Nigel Spry, University of Western Australia
David Joseph, University of Western Australia
Robert Newton, Edith Cowan UniversityFollow

Document Type

Journal Article

Faculty

Faculty of Computing, Health and Science

School

ECU Health and Wellness Institute

RAS ID

12543

Comments

Galvao, D. A., Taaffe, D., Spry, N., Joseph, D., & Newton, R. (2011). Acute versus chronic exposure to androgen suppression for prostate cancer: Impact on the exercise response. Journal of Urology, 186(4), 1291-1297. Available here

Abstract

Exercise has been proposed as an effective countermeasure for androgen suppression therapy induced side effects. Since the magnitude of fat gain and muscle loss is most pronounced during the early phases of androgen suppression therapy, the exercise response may differ by the duration of androgen suppression therapy. We investigated whether the exercise response varied by the prior duration of exposure to androgen suppression therapy, that is acute—less than 6 months vs later—6 months or greater.

DOI

10.1016/j.juro.2011.05.055

Access Rights

subscription content